Katherine Denney, Alissa Fleming, Gregory Fliszar Ph.D. On August 1, 2025, the Health Resources and Services Administration (HRSA), administrator of the 340B Drug Pricing Program, announced its ...

The 340B drug discount program incentivizes hospitals to purchase outpatient clinics and prescribe more and higher-cost drugs — behaviors that tend to increase costs for the federal government and ...

Four drug manufacturers have announced plans to offer discounted drug prices to safety net providers under the federal 340B program via rebates instead of upfront discounts, despite the federal ...

This past September, a sub-agency of the Department of Health and Human Services (HHS) threatened to kick a pharmaceutical company out of Medicare because the company, in line with federal law, ...

Senator calls on Congress to increase oversight of the 340B Drug Pricing Program by requiring participating providers to complete annual reports on program savings and revenues. If your health system ...

Drug companies are at it again. They will not relent in their multiyear campaign to dismantle the 340B Drug Pricing Program. Drug companies are at it again. They will not relent in their multiyear ...

"The ongoing abuse of 340B and Medicaid discounts is enriching huge hospital conglomerates at the expense of patients, employers, state governments, poor communities, and taxpayers," writes Pipes.

I woke up in a hospital to learn I was given a new name. Almond T. Rectangle. In May 2024, I suffered a cardiac arrest while less than 40 miles away from my home in Brunswick. I don’t remember any of ...